A. S. Tulbah, “Formulation and in vitro characterization of inhalable dasatinib-nanoemulsion as a treatment potential against A549 and Calu-3 lung cancer cells”, IJHS, vol. 19, no. 1, pp. 4–14, Jan. 2025.